NuLids
JETT Plasma - Dry Eye treatment
Are you tired of the discomfort, irritation, and redness caused by dry eye? Experience a revolutionary, non-invasive solution with the JETT Plasma Pen at Kalamalka Eye Care.
Health Canada Approved
This cutting-edge, Health Canada-approved treatment targets the root causes of dry eye, including Meibomian Gland Dysfunction (MGD) and blepharitis, delivering clinically proven results with minimal downtime.
Clinically Proven
With a success rate of over 80% in alleviating symptoms of blepharitis and MGD, this treatment is transforming eye care
Why Choose JETT Plasma Pen for Dry Eye?
Clinically Proven Relief: Studies show that JETT Plasma Pen therapy significantly improves dry eye symptoms, with 70.2% of patients experiencing enhanced tear film stability and reduced inflammation after just four sessions over four weeks.1
Non-Invasive and Comfortable: Using advanced plasma technology, the JETT Plasma Pen gently stimulates meibomian gland function to restore the tear film’s oil layer, reducing evaporation and dryness without surgery.
Long-Lasting Results: Patients report symptom relief lasting 6 months to 3 years or more, with single maintenance treatments to sustain comfort.2
Aesthetic Benefits: Beyond dry eye relief, the treatment promotes collagen production, tightening and rejuvenating the delicate skin around the eyes for a youthful appearance.
How It Works
The JETT Plasma Pen uses direct current (DC) plasma energy to deliver precise micro-discharges to the eyelid and conjunctival areas. This process:
Depolarizes cell membranes to enhance nutrient flow and reduce inflammation.
Breaks down blockages in meibomian glands, improving oil flow for better tear quality.
Stimulates natural healing, with immediate symptom improvement reported by many patients after the first session.3
Real Results, Backed by Science
A 2022 study presented at the European Society of Cataract and Refractive Surgeons found that patients treated with JETT Plasma Pen experienced a significant reduction in Ocular Surface Disease Index (OSDI) scores, indicating improved comfort and quality of life. Additionally, tear break-up time (TBUT) increased, showing enhanced tear film stability. With a success rate of over 80% in alleviating symptoms of blepharitis and MGD, this treatment is transforming eye care.
NuLids
Cleanse & Microexfoliation
Experience professional-grade relief from blepharitis, Meibomian Gland Dysfunction (MGD), and dry eye symptoms. NuLids Pro, developed by leading corneal specialist Dr. John Olkowski, is a cutting-edge in-office treatment that gently cleanses and massages the eyelid margins to promote healthier tears and reduce inflammation. Click here to learn more about the treatment.
Why Choose NuLids Pro?
Clinically Proven Relief: Targets the root causes of dry eye by improving Meibomian gland function and tear quality.
Fast and Effective: Delivers noticeable results in just one minute per treatment.
Gentle and Safe: Features a self-regulating design that ensures comfort and stops if too much pressure is applied
Supports Eyelid and Lash Health: Improves cleanliness, aiding lash extension retention and overall eye comfort.
Clinically Proven Results
NuLids Pro has been rigorously tested, delivering measurable improvements in clinical studies:
64% Improvement in Tear Break-Up Time (TBUT): Enhances tear film stability for lasting moisture.
81% Improvement in Meibomian Gland Secretions: Promotes healthier gland function.
21% Improvement in Meibomian Gland Scores: Reflects better gland structure.
48% Reduction in Ocular Staining: Indicates less corneal and conjunctival damage.
50% Improvement in OSDI Scores: Patients report significantly reduced dry eye symptoms.
3% Reduction in Tear Osmolarity: Suggests improved tear quality after 30 days.
Before/after
Before
After
Zest - Lid Cleanse
Discover Lasting Relief with ZEST In-Office Eyelid Cleanse!
Are dry, irritated eyes holding you back? Experience the revolutionary ZEST (Zocular Eyelid System Treatment), an advanced in-office procedure designed to tackle the root causes of dry eye, blepharitis, and Demodex mites. With ZEST, you can enjoy soothing, long-lasting relief and healthier eyes in just one quick, comfortable session.
Why Choose ZEST?
Deep-Cleansing Power: Using a natural okra-based gel, ZEST gently yet effectively removes debris, bacteria, and mites from your eyelids and lashes, promoting a healthier tear film.
Immediate Comfort: This painless, 5-12 minute treatment leaves your eyes feeling refreshed, rejuvenated, and free from irritation.
Targets the Source: ZEST addresses Meibomian Gland Dysfunction, a leading cause of dry eye, by clearing blockages and restoring natural oil flow for better tear production.
Safe and Natural: Formulated with okra, a gentle yet powerful ingredient, ZEST soothes inflammation while cleansing without harsh chemicals or anesthetics.
How It Works
During the ZEST treatment, your eye doctor applies a specialized okra-based gel to your eyelids using a sterile swab. The gel is gently massaged to create a lather, lifting away oil, dirt, and irritants. After a thorough cleanse, the gel is rinsed off with saline, leaving your eyelids clean, calm, and revitalized.
Endoret PRGF: Transform Your Dry Eye Treatment
Experience a breakthrough in dry eye treatment with Endoret® PRGF® (Plasma Rich in Growth Factors) from Labtician Ophthalmics, a cutting-edge, natural solution that uses your body’s own healing power to alleviate dry eye symptoms. Unlike traditional artificial tears, Endoret PRGF eye drops are derived from your blood, delivering a safe, biocompatible therapy rich in growth factors and anti-inflammatory agents to repair the ocular surface and provide long-lasting comfort.
Why Choose Endoret PRGF for Dry Eye?
Dry eye disease affects millions, causing irritation, redness, and vision discomfort. For moderate to severe cases, conventional treatments often fall short. Endoret PRGF, developed by Labtician Ophthalmics, offers a personalized solution that promotes tissue regeneration and reduces inflammation, addressing the root causes of dry eye for sustained relief.
Clinically Proven Results
Endoret PRGF is backed by rigorous clinical studies, demonstrating its efficacy in treating dry eye disease:
87.5% of patients reported significant symptom improvement after 6 weeks of PRGF therapy [PubMed, 2017].
78% showed enhanced tear production and ocular surface health within 3 months [Clinical Ophthalmology, 2018].
94% of patients with severe dry eye, including those with Sjögren’s syndrome, experienced reduced inflammation and improved comfort [Journal of Ophthalmology, 2020].
PRGF eye drops stimulate scarless regeneration of ocular surface stromal fibroblasts, outperforming autologous serum [Exp Eye Res, 2015].
These results highlight Endoret PRGF’s superiority over traditional treatments, making it a trusted choice for eye care professionals and patients.
Why Choose Endoret PRGF for Dry Eye?
Endoret PRGF is a closed-system technology that uses disposable, single-use kits to prepare plasma under sterile conditions, ensuring safety and consistency. The platelet-rich plasma releases growth factors that repair damaged ocular tissues and reduce inflammation, offering rapid and lasting relief. Patients often notice improvements within weeks, with results that enhance daily comfort and quality of life.
Ophthalogix Amniotic Membrane
Discover the future of eye care with Ophthalogix’s cutting-edge amniotic membrane treatments—Eclipse and Aurora. Designed for optometrists and ophthalmologists, our premium, 100% organic amniotic membrane grafts offer unparalleled healing for patients suffering from dry eye disease and other corneal conditions.
Why Choose Ophthalogix?
Our innovative Eclipse and Aurora amniotic membrane treatments (AMT) are revolutionizing the management of ocular surface disorders. Backed by rigorous clinical studies, these treatments deliver exceptional results for conditions like dry eye disease (DED), neurotrophic keratitis, corneal ulcers, and more.
88% of patients with severe dry eye showed significant improvement in ocular surface health after treatment with cryopreserved amniotic membrane (CAM), with effects lasting up to 3 months.1
95% of patients in a study of 160 participants reported that CAM healed their eye, and 81% noted improved vision.2
Clinically Proven Benefits
Accelerated Healing: Eclipse and Aurora provide a biologically active scaffold rich in growth factors, promoting rapid corneal nerve regeneration and epithelial healing.3
Anti-Inflammatory Power: Reduces inflammation and scarring, addressing the root causes of chronic dry eye and corneal damage.4
Enhanced Patient Comfort: Aurora’s unique central aperture design minimizes vision impairment, ensuring patient comfort during treatment.5
Versatile Applications: Effective for severe dry eye, neurotrophic keratitis, recurrent corneal erosions, and chemical or thermal injuries.6
DEWS Score Reduction: In a multi-center study, the Dry Eye Workshop (DEWS) score dropped from 3.25 to 1.47 after CAM treatment, indicating a significant reduction in dry eye severity.7
References:
1. McDonald MB, et al. Clin Ophthalmol. 2018.
2. Review of Optometry. 2022.
3. John T, et al. J Ophthalmol. 2017.
4. Mead OG, et al. Taiwan J Ophthalmol. 2020.
5. Ophthalogix LinkedIn. 2025.
6. Veldman PB, et al. American Academy of Ophthalmology.
7. McDonald MB, et al. Clin Ophthalmol. 2018.
8. Ophthalogix. 2020.
9. Healio. 2018.